title: The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788].
abstract: BACKGROUND
  Survivors of transient ischemic attack (TIA) or stroke are at high risk for recurrent vascular events and aggressive treatment of vascular risk factors can reduce this risk. However, vascular risk factors, especially hypertension and high cholesterol, are not managed optimally even in those patients seen in specialized clinics. This gap between the evidence for secondary prevention of stroke and the clinical reality leads to suboptimal patient outcomes. In this study, we will be testing a pharmacist case manager for delivery of stroke prevention services. We hypothesize this new structure will improve processes of care which in turn should lead to improved outcomes.
  
  
  METHODS
  We will conduct a prospective, randomized, controlled open-label with blinded ascertainment of outcomes (PROBE) trial. Treatment allocation will be concealed from the study personnel, and all outcomes will be collected in an independent and blinded manner by observers who have not been involved in the patient's clinical care or trial participation and who are masked to baseline measurements. Patients will be randomized to control or a pharmacist case manager treating vascular risk factors to guideline-recommended target levels. Eligible patients will include all adult patients seen at stroke prevention clinics in Edmonton, Alberta after an ischemic stroke or TIA who have uncontrolled hypertension (defined as systolic blood pressure (BP) > 140 mm Hg) or dyslipidemia (fasting LDL-cholesterol > 2.00 mmol/L) and who are not cognitively impaired or institutionalized. The primary outcome will be the proportion of subjects who attain 'optimal BP and lipid control'(defined as systolic BP < 140 mm Hg and fasting LDL cholesterol < 2.0 mmol/L) at six months compared to baseline; 12-month data will also be collected for analyses of sustainability of any effects. A variety of secondary outcomes related to vascular risk and health-related quality of life will also be collected.
  
  
  CONCLUSIONS
  Nearly one-quarter of those who survive a TIA or minor stroke suffer another vascular event within a year. If our intervention improves the provision of secondary prevention therapies in these patients, the clinical (and financial) implications will be enormous.
authors.affiliation: Division of General Internal Medicine, University of Alberta Hospital, 8440 112 Street, Edmonton, Canada. finlay.mcalister@ualberta.ca
authors.forename: Finlay A
authors.initials: FA
authors.lastname: McAlister
authors.forename: Sumit R
authors.initials: SR
authors.lastname: Majumdar
authors.forename: Rajdeep S
authors.initials: RS
authors.lastname: Padwal
authors.forename: Miriam
authors.initials: M
authors.lastname: Fradette
authors.forename: Ann
authors.initials: A
authors.lastname: Thompson
authors.forename: Ross
authors.initials: R
authors.lastname: Tsuyuki
authors.forename: Steven A
authors.initials: SA
authors.lastname: Grover
authors.forename: Naeem
authors.initials: N
authors.lastname: Dean
authors.forename: Ashfaq
authors.initials: A
authors.lastname: Shuaib
references.citation: JAMA. 2006 Dec 6;296(21):2563-71
references.pmid: 17101639
references.citation: N Engl J Med. 2008 Sep 18;359(12):1225-37
references.pmid: 18753639
references.citation: Stroke. 2002 Jun;33(6):1656-9
references.pmid: 12053007
references.citation: Stroke. 2007 Dec;38(12):3198-204
references.pmid: 17962589
references.citation: CMAJ. 2008 Feb 26;178(5):576-84
references.pmid: 18299547
references.citation: J Am Coll Cardiol. 2004 May 19;43(10):1738-42
references.pmid: 15145092
references.citation: Lancet. 2001 Sep 29;358(9287):1033-41
references.pmid: 11589932
references.citation: Stroke. 2007 Jun;38(6):1881-5
references.pmid: 17431209
references.citation: Can J Cardiol. 2008 Jun;24(6):465-75
references.pmid: 18548143
references.citation: Medicine (Baltimore). 2008 Nov;87(6):329-334
references.pmid: 19011504
references.citation: J Am Geriatr Soc. 1975 Oct;23(10):433-41
references.pmid: 1159263
references.citation: J Gen Intern Med. 2005 Dec;20(12):1091-6
references.pmid: 16423096
references.citation: Pharmacotherapy. 2000 Dec;20(12):1508-16
references.pmid: 11130223
references.citation: J Hypertens. 2006 Jun;24(6):1201-8
references.pmid: 16685221
references.citation: Stroke. 1999 Jan;30(1):16-20
references.pmid: 9880382
references.citation: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005182
references.pmid: 16625627
references.citation: Can J Cardiol. 2009 Oct;25(10):567-79
references.pmid: 19812802
references.citation: Lancet. 2007 Jan 27;369(9558):283-92
references.pmid: 17258668
references.citation: Lancet. 2007 Dec 1;370(9602):1829-39
references.pmid: 18061058
references.citation: Osteoporos Int. 2007 Mar;18(3):261-70
references.pmid: 17086470
references.citation: Ann Pharmacother. 2007 Nov;41(11):1770-81
references.pmid: 17925496
references.citation: J Manag Care Pharm. 2003 May-Jun;9(3):269-73
references.pmid: 14613471
references.citation: Lancet. 2007 Oct 20;370(9596):1432-42
references.pmid: 17928046
references.citation: Stroke. 2003 Nov;34(11):2741-8
references.pmid: 14576382
references.citation: Diabetes Care. 2003 Nov;26(11):3061-6
references.pmid: 14578240
references.citation: JAMA. 2002 Sep 18;288(11):1388-95
references.pmid: 12234233
references.citation: N Engl J Med. 2006 Aug 10;355(6):549-59
references.pmid: 16899775
references.citation: Lancet. 2005 Oct 8;366(9493):1267-78
references.pmid: 16214597
references.citation: Am Heart J. 2007 Jan;153(1):22.e1-8
references.pmid: 17174632
references.citation: Am J Hypertens. 1997 Oct;10(10 Pt 1):1097-102
references.pmid: 9370379
references.citation: Cochrane Database Syst Rev. 2000;(3):CD000336
references.pmid: 10908471
references.citation: Am J Med. 2007 Aug;120(8):734.e11-7
references.pmid: 17679135
references.citation: J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):23-31
references.pmid: 18192127
references.citation: Stroke. 1997 Dec;28(12):2557-62
references.pmid: 9412649
references.citation: Neurology. 2004 Jun 8;62(11):2015-20
references.pmid: 15184607
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: J Gen Intern Med. 2009 Jan;24(1):33-9
references.pmid: 18937013
references.citation: CMAJ. 2009 Dec 8;181(12):E267-74
references.pmid: 19948811
references.citation: Arch Intern Med. 2007 Nov 26;167(21):2296-303
references.pmid: 18039987
references.citation: Fam Pract. 2007 Apr;24(2):189-200
references.pmid: 17272285
references.citation: Ann Intern Med. 2005 Nov 1;143(9):659-72
references.pmid: 16263889
references.citation: Lancet. 2002 Nov 2;360(9343):1347-60
references.pmid: 12423980
references.citation: Stroke. 1988 May;19(5):604-7
references.pmid: 3363593
references.citation: CMAJ. 2004 Nov 9;171(10):1189-92
references.pmid: 15534311
references.citation: CMAJ. 2006 Apr 25;174(9):1267-71
references.pmid: 16595786
references.citation: J Hypertens. 2007 May;25(5):951-8
references.pmid: 17414657
references.citation: Can J Neurol Sci. 2005 Nov;32(4):496-500
references.pmid: 16408581
references.citation: CMAJ. 2008 May 20;178(11):1418-25
references.pmid: 18490636
references.citation: JAMA. 2006 Jul 26;296(4):427-40
references.pmid: 16868301
references.citation: Arch Intern Med. 2002 May 27;162(10):1149-55
references.pmid: 12020186
references.citation: Lancet. 2008 Sep 27;372(9644):1174-83
references.pmid: 18757085
references.citation: Eur Heart J. 2003 Nov;24(21):1920-7
references.pmid: 14585250
references.citation: Pharmacotherapy. 2000 Nov;20(11):1375-83
references.pmid: 11079286
references.citation: CMAJ. 2005 Aug 30;173(5):496-501
references.pmid: 16129870
references.citation: Arch Intern Med. 2008 Nov 24;168(21):2355-61
references.pmid: 19029501
references.citation: Neurology. 2005 Sep 27;65(6):835-42
references.pmid: 16186519
references.citation: Lancet. 2004 Sep 11-17;364(9438):937-52
references.pmid: 15364185
references.citation: Health Rep. 2010 Mar;21(1):37-46
references.pmid: 20426225
references.citation: CMAJ. 2009 Dec 8;181(12):897-904
references.pmid: 19933787
references.citation: Arch Intern Med. 2007 May 28;167(10):1019-25
references.pmid: 17533204
references.citation: Lancet. 2003 Nov 8;362(9395):1527-35
references.pmid: 14615107